Application of the concetrations ratio of soluble receptor tyrosine kinase type 1, and placental growth factor for short-term prediction and diagnosis of preeclampsia;Využití poměru koncentrací solubilního receptoru tyrozinkinázového typu 1 a placentárního růstového faktoru pro krátkodobou predikci a diagnostiku preeklampsie

Ceska Gynekologie

Volumn 81, Issue 4, 2016, Pages 272-278

  Bubenikova S ^a   Cichova A ^a   Roubalova L ^b   Durdova V ^c   Vlk, R ^d  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b Oddeleni Klinicke Biochemie   (Czech Republic)

^c I chirurgicka klinika FN   (Czech Republic)

^d UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Angiogenic factors; Placental growth factor PlGF; Prediction; Preeclampsia; SFlt 1; Soluble fms like tyrosine kinase; The sFlt 1 PlGF ratio

Indexed keywords

BIOLOGICAL MARKER; FLT1 PROTEIN, HUMAN; PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

BLOOD; FEMALE; HUMAN; PRE-ECLAMPSIA; PREGNANCY;

BIOMARKERS; FEMALE; HUMANS; PLACENTA GROWTH FACTOR; PRE-ECLAMPSIA; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 85002678514     PISSN: 12107832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Akolekar, R., Zaragoza, E., Poon, LC., et al. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol, 2008, 32(6), p. 732-739. Dostupné z doi:10.1002/uog.6244.
2. Burton, GJ. Oxygen, the janus gas, its effects on human placental development and functions. J Anatomy, 2009, 215(1), p. 27-35. Dostupné z doi: 10.1111/j.1469-7580.2008.00978.x.
3. Cerdeira, AS., Karumanchi, SA. Angiogenic factors in preeclampsia and related disorders. Cold Spring Harb Perspect Med, 2012, 2(11). Dostupné z doi: 10.1101/cshperspect.a006585.
4. Hájek, Z. Rizikové a patologické těhotenství. Praha: Grada Publishing, 2004, 443 s.
5. Hájek, Z., Čech, E., Maršál K. Porodnictví 3, zcela přepracované a doplněné vydání. Praha: Grada, 2014, 580 s.
6. Herraiz, I., Simón, E., Gómez-Arriaga P., et al. Angiogenesisrelated biomarkers (sFlt-1/PlGF) in the prediction and diagnosis of placental dysfunction: an approach for clinical integration. Inter J Molecular Sci, 2015, 16(8), p. 19009-19026. Dostupné z doi: 10.3390/ijms160819009.
7. Hund, M., Allegranza, D., Schoedl, M., et al. Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol. BMC Pregnancy and Childbirth, 2014, 14(1), p. 324. Dostupné z doi: 10.1186/1471-2393-14-324.
8. Chamy, VM., Lepe, J., Catalán, Á., et al. Oxidative stress is closely related to clinical severity of pre-eclampsia. Biol Res, 2006, 39(2). Dostupné z doi: 10.4067/S0716-97602006000200005.
9. Lai, J., Poon, LCY., Bakalis, S., et al. Systolic, diastolic and mean arterial pressure at 30-33 weeks in the prediction of preeclampsia. Fetal Diag Ther, 2013, 33(3), p. 173-181. Dostupné z doi: 10.1159/000345950.
10. Leahomschi, S., Calda, P. Preeklampsie v těhotenství - predikce, prevence a další management. Čes Gynek, 2014, 79(5), s. 356-362.
11. Levine, R., Maynard, SE., Qian, C., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med, 2004, 350(7), p. 672-683.
12. Levine, RJ., Lam, C., Qian, C., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med, 2006, 355(10), p. 992-1005.
13. Magee, LA., Pels, A., Helewa, M., et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertension. Inter J Women's Cardiovascular Health, 2014, 4(2), p. 105-145 Dostupné z doi: 10.1016/j.preghy.2014.01.003.
14. Maynard, SE., Karumanchi, SA. Angiogenic factors and preeclampsia. Seminars in Nephrology, 2011, 31(1), p. 33-46. Dostupné z doi: 10.1016/j.semnephrol.2010.10.004.
15. Maynard, SE., Min, JY., Merchan, J., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt-1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest, 2003, 111(5), p. 649-658.
16. Pereira, RD., Long, NE., Wang, R.C., et al. Angiogenesis in the placenta: the role of reactive oxygen species signaling. BioMed Res Inter, 2015. Dostupné z doi:10.1155/2015/814543.
17. Reynolds, LP., Redmer, DA. Angiogenesis in the placenta. Biol Reprod, 2001, 64(4), p. 1033-1040.
18. Staff, AC., Benton, SJ., Dadelszen, P., et al. Redefining preeclampsia using placenta-derived biomarkers. Hypertension, 2013, 61(5), p. 932-942. Dostupné z doi: 10.1161/HYPERTENSIONAHA.111.00250.
19. Stepan, H., Herraiz, I., Schlembach, D., et al. Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice. Ultrasound Obstet Gynecol, 2015, 45(3), p. 241-246. Dostupné z: http://doi.wiley.com/10.1002/uog.14799.
20. Thomas, CP., Andrews, JI., Liu, KZ. Intronic polyadelation signal sequences and alternace splicing generace human soluble Flt-1 variants and regulace the abundance of soluble Flt-1 in the placenta. FASEB J, 2007, 21(14), p. 3885-3895.
21. Tsiakkas, A., Duvdevani, N., Wright, A., et al. Serum soluble fms-like tyrosine konase-1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol, 2015, 45(5), p. 584-590. Dostupné z doi: 10.1002/uog.14817.
22. Tsiakkas, A., Duvdevani, N., Wright, A., et al. Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol, 2015, 45(5), p. 591-598. Dostupné z doi: 10.1002/uog.14811.
23. Verlohren, S., Herraiz, I., Lapaire, O., et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol, 2012, 206(1). Dostupné z doi: 10.1016/j.ajog.2011.07.037.
24. Vlk, R. Preeklampsie. Praha: Maxdorf, 2015, 349 s.
25. Wang, A., Rana, S., Karumanchi, SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology, 2009, 24(3), p. 147-158. Dostupné z doi: 10.1152/physiol.00043.2008.
26. Zeisler, H., Llurba, E., Chantraine, F., et al. Predictive value of the sflt-1: plgf ratio in women with suspected preeclampsia. New Engl J Med, 2016, 1(7), p. 13-22. Dostupné z doi: 10.1056/NEJMoa1414838.